Giovanni Meola Selected Research

Myotonic Dystrophy (Dystrophia Myotonica)

12/2021	Co-occurrence of DMPK expansion and CLCN1 mutation in a patient with myotonia.
1/2021	Lesion distribution and substrate of white matter damage in myotonic dystrophy type 1: Comparison with multiple sclerosis.
12/2020	Myotonic dystrophy type 2: the 2020 update.
1/2020	Ventral tegmental area dysfunction affects decision-making in patients with myotonic dystrophy type-1.
1/2020	Rare Disease: Cardiac Risk Assessment With MRI in Patients With Myotonic Dystrophy Type 1.
8/2019	Consensus-based care recommendations for adults with myotonic dystrophy type 2.
4/2019	Dysregulation of Circular RNAs in Myotonic Dystrophy Type 1.
1/2019	Aberrant insulin receptor expression is associated with insulin resistance and skeletal muscle atrophy in myotonic dystrophies.
1/2019	TNNT2 Missplicing in Skeletal Muscle as a Cardiac Biomarker in Myotonic Dystrophy Type 1 but Not in Myotonic Dystrophy Type 2.
12/2018	Consensus-based care recommendations for adults with myotonic dystrophy type 1.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giovanni Meola Research Topics

Disease

30	Myotonic Dystrophy (Dystrophia Myotonica) 12/2021 - 10/2003
6	Myotonia 12/2021 - 10/2012
5	Muscular Diseases (Myopathy) 01/2019 - 02/2011
4	Cognitive Dysfunction 01/2020 - 09/2007
3	Myotonia Congenita (Thomsen Disease) 12/2021 - 07/2012
3	Insulin Resistance 01/2019 - 09/2007
2	Channelopathies 01/2018 - 02/2017
2	Muscle Weakness 12/2012 - 07/2012
1	Frontotemporal Dementia (Semantic Dementia) 01/2022
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2022
1	Multiple Sclerosis 01/2020
1	Familial Mediterranean Fever (Periodic Disease) 01/2020
1	Minicore Myopathy with External Ophthalmoplegia 01/2019
1	Atrophy 01/2019
1	Parkinsonian Disorders (Parkinsonism) 01/2018
1	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 01/2018
1	Myasthenia Gravis 01/2018
1	Autonomic Nervous System Diseases (Dysautonomia) 01/2018
1	Syncope (Fainting) 01/2018
1	Thymoma (Thymic Carcinoma) 01/2018
1	Thymus Neoplasms (Thymus Neoplasm) 01/2018
1	Brugada Syndrome 01/2018
1	Sporadic Creutzfeldt-Jakob Disease 01/2018
1	Edema (Dropsy) 02/2017
1	Posterior Leukoencephalopathy Syndrome 01/2017
1	Inborn Genetic Diseases (Disease, Hereditary) 12/2016
1	Paralysis (Palsy) 04/2016
1	Hypogonadism (Hypergonadotropic Hypogonadism) 07/2015
1	Sarcopenia 01/2014
1	Nondystrophic myotonia 10/2012
1	Rare Diseases (Rare Disease) 10/2012
1	Migraine Disorders (Migraine) 03/2010
1	Patent Foramen Ovale 03/2010
1	Ischemia 10/2009
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 10/2009
1	Spastic Paraparesis 04/2008
1	Atherosclerosis 09/2007
1	Migraine with Aura (Familial Hemiplegic Migraine) 02/2006
1	Type 2 Episodic Ataxia 02/2006

Drug/Important Bio-Agent (IBA)

8	RNA (Ribonucleic Acid)IBA 12/2020 - 10/2004
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2009
5	MicroRNAs (MicroRNA)IBA 07/2015 - 10/2009
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 06/2014
4	3' Untranslated Regions (3' UTR)IBA 09/2018 - 10/2003
3	Chloride Channels (Chloride Channel)IBA 12/2021 - 07/2012
3	Mexiletine (Mexitil)FDA LinkGeneric 12/2021 - 10/2012
3	Messenger RNA (mRNA)IBA 04/2019 - 04/2010
2	Protein Kinases (Protein Kinase)IBA 12/2021 - 01/2013
2	N-desmethylstobadineIBA 12/2021 - 10/2012
2	milk-derived factorIBA 08/2019 - 12/2018
2	Insulin (Novolin)FDA Link 01/2019 - 01/2017
2	Insulin ReceptorIBA 01/2019 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 01/2018
2	SodiumIBA 01/2018 - 02/2017
2	Sodium Channels (Sodium Channel)IBA 02/2017 - 10/2012
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 11/2011 - 05/2009
1	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2021
1	Complex MixturesIBA 01/2020
1	Rituximab (Mabthera)FDA Link 01/2020
1	Circular RNAIBA 04/2019
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 01/2019
1	Glycoproteins (Glycoprotein)IBA 01/2019
1	MethyltransferasesIBA 01/2019
1	CalciumIBA 01/2019
1	Selenoproteins (Selenoprotein)IBA 01/2019
1	Flecainide (Tambocor)FDA LinkGeneric 01/2018
1	Methionine (L-Methionine)FDA Link 01/2018
1	Immunoglobulins (Immunoglobulin)IBA 01/2018
1	Peptides (Polypeptides)IBA 01/2018
1	PrionsIBA 01/2018
1	AntibodiesIBA 01/2018
1	Anti-Arrhythmia AgentsIBA 01/2018
1	Amino Acids FDA Link 01/2018
1	Ajmaline (Wolfina)FDA Link 01/2018
1	RNA-Induced Silencing ComplexIBA 01/2018
1	CLC-1 channelIBA 01/2018
1	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2017
1	TroponinIBA 12/2017
1	Sunitinib (Sutent)FDA Link 01/2017
1	Troponin T (Troponin T1)IBA 12/2016
1	NucleotidesIBA 12/2016
1	Dichlorphenamide (Daranide)FDA Link 04/2016
1	MD1IBA 07/2015
1	DEAD-box RNA HelicasesIBA 06/2015
1	Cyclin D3IBA 12/2012
1	Ion Channels (Ion Channel)IBA 10/2012
1	Carrier Proteins (Binding Protein)IBA 11/2011
1	A-Form DNA (A-DNA)IBA 05/2010
1	ProteomeIBA 05/2010
1	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 03/2010
1	DystrophinIBA 10/2009
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 04/2008
1	ChemokinesIBA 09/2007
1	AdipokinesIBA 09/2007
1	Calcium Channels (Calcium Channel)IBA 02/2006

Therapy/Procedure

1	Thymectomy 01/2018
1	Defibrillators (Defibrillator) 01/2018
1	Activities of Daily Living (ADL) 01/2016
1	Secondary Prevention 03/2010